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Abstract 
We formed a collaborative to spread effective MRSA prevention strategies. We conducted a two-phase, multisite, 
quasi-experimental study of seven hospital systems (11 hospitals) in IN, MT, ME and Ontario, Canada over six 
years. Patients with prior MRSA were identified at admission using regional health information exchange data. We 
developed a system to return an alert message indicating a prior history of MRSA, directed to infection 
preventionists and admissions. Alerts indicated the prior anatomic site, and the originating institution.   The 
combined approach of training and coaching, implementation of MRSA registries, notifying hospitals on admission 
of previously infected or colonized patients, and change strategies was effective in reducing MRSA infections over 
80%. Further research and development of electronic surveillance tools is needed to better integrate the varied data 
source and support preventing MRSA infections. Our study supports the importance of hospitals collaborating to 
share data and implement effective strategies to prevent MRSA.  
Introduction 
Methicillin-resistant S. aureus (MRSA) is an important cause of healthcare-associated infections, both in hospitals 
and in the community.1 Furthermore, effective strategies to prevent MRSA have been implemented and shown to be 
effective.2 
To support efforts to reduce MRSA infections, we organized a MRSA Prevention Collaborative to identify barriers, 
develop common definitions and procedures, and share successful strategies among participating hospitals. We also 
implemented a social-change staff training program consisting of evidence-based infection prevention precautions in 
hospitals. Using Lean and Positive Deviance (PD) training, we supported the implementation of MRSA prevention 
practices by hospital staff teams, with professional coaches from the Plexus Institute, which helps people apply 
concepts from complexity science. 3 
Intervention 
An overall goal of the project was to foster spread of the MRSA Intervention Bundle to other hospital units and 
additional hospitals.  The MRSA Intervention Bundle, based on published literature, experience with other MRSA 
reduction collaboratives, and our previous work of MRSA reduction, consisted of (1) active surveillance cultures for 
all patients admitted to study units, (2) pre-emptive barrier isolation of those identified as either infected or 
colonized with MRSA, and (3) institution of strict hand-hygiene before and after each patient contact.2,4 The 
implementation of these MRSA prevention practices by hospital staff teams was supported by Lean and PD training, 
professional coaching, and participation in a MRSA Reduction Collaborative. The aims of this collaborative were 
setting goals, identifying barriers to using infection control practices, and sharing successful strategies for increasing 
successful infection control practices.5-10 
A second overall goal was to evaluate the effectiveness of the implementation strategies, foster learning among the 
participants by applying technology and multi-method approaches to enable automated collection, sharing, analysis 
and reporting of data, and identify institutional factors predicting success.  We conducted a quasi-experimental 
study in a sample of hospitals to assess changes in MRSA infection rates over time and to relate differences in rates 
to implementation processes, adherence to MRSA bundle components, context, use of social networks, and 
technology use. Implementation included developing local goals and making changes to infection control practices. 
The implementation was evaluated through the application of information technology to enable consistent 
collection, sharing, and reporting of data related to MRSA intervention implementation, such as baseline and follow-




A third overall goal was to build a growing network of people and organizations devoted to MRSA prevention as a 
means to foster learning, disseminate findings, and stimulate new action.  Our Dissemination and Outreach Plan 
sought to disseminate findings and provide recommendations for other individuals, systems, organizations and 
programs interested in implementing MRSA reduction programs. Through our work, we developed a mechanism for 
key organizations with an interest in MRSA prevention, and other regional safety and quality collaboratives, to learn 
from the work of this initiative. We worked closely with our AHRQ project officer and CDC liaisons, the Plexus 
Institute, the RWJ Foundation, the Indianapolis Patient Safety Coalition, IN Patient Safety Center, and other MRSA 
collaboratives to foster dialogue, active teamwork and partnership in the active transfer of “common knowledge” in 
what works.   
Hospital Selection 
In 2009, a committee of individuals (operations, coaches and investigators) organized a competitive request for 
proposal process, to invite potentially interested hospitals to submit applications to participate in this study. The 
committee reviewed and discussed each application, selecting seven hospital systems that were committed to 
reducing MRSA in their organizations.  Our on-site facilitators (one each in Lean and in PD) were assigned to work 
with interested staff teams at each facility to engage leadership, conduct discovery and action dialogues, select target 
units and team members, and drive implementation-and-spread activities. These activities included training hospital 
staff in facilitation, developing implementation plans, creating and implementing strategies to broaden staff 
engagement, planning rapid process change cycles, implementing solutions for locally identified barriers to using 
MRSA bundle practices, and assessing impact using feedback tools.  
The seven hospital systems selected to participate in this project were: Clarian Health (now IU Health), Indianapolis, 
IN; Community Health Network, Community North, Indianapolis, IN; Maine Health, Maine Medical Center, 
Portland, ME; St. Patrick Hospital, Missoula, MT; St. Francis Hospital and Health, Indianapolis, IN; St. Vincent 
Health, St. Vincent Hospital, Indianapolis, IN; University Health Network, Toronto, Ontario; Dialysis Units, Maine. 
Informatics Infrastructure 
The Indianapolis health care systems utilize, and are connected by, the Indiana Network Patient for Patient Care 
(INPC) interface called Careweb, which was developed by the Regenstrief Institute. Careweb is a secure web-based 
application built upon the INPC’s extensive network of real-time electronic interfaces to the hospital information 
systems.  
For the purposes of this project, we developed electronic alerts of positive MRSA cases between hospitals and 
hospital systems. Our RHIO generates an Admission-Discharge Transfer (ADT) message indicating that a patient is 
being admitted to any of the Indianapolis hospitals. We developed a program which examines that patient's health 
information exchange (HIE) record to check if there is evidence of prior MRSA infection (e.g. a diagnosis or culture 
result in the HIE record from every microbiology lab in Indiana). If evidence of prior MRSA is found, then asecure 
email message is sent back to the registrar and infection preventionists at the admitting institution indicating the 
patient’s prior history of MRSA and site of infection and including a link to login to Careweb for additional details.   
As part of this study, we designed and implemented a database system to take advantage of existing electronic data 
sharing with Regenstrief Institute, Inc., to facilitate collection, measurement, and reporting of MRSA clinical 
incidence. We validated this approach and linked measurement of clinical incidence with near real time process 
measures relevant to the prevention of MRSA infections.  
Data Measures 
Standard measures for MRSA colonization and infection rates were collected at the participating hospitals over time. 
The primary measure was the rate of the number of nosocomial blood stream infections caused by MRSA per 1,000 
patient days collected over time before (pre-implementation period of 2 years before implementation) and after 
(post-implementation period of 1 year after implementation) the intervention program.  Secondary measures 
included central line associated bloodstream infections (CLABSI - laboratory confirmed bloodstream infection in 
patient with a central line at the time of [or within 48-hours prior to] the onset of symptoms, and infection is not 
related to an infection from another site) and hospital-acquired infections (HAI – laboratory confirmed infection 
occurring greater than 48 hours after hospital admission) with MRSA, although data on these infections was not 




Adherence to bundle components was collected on a monthly basis by project staff, in order to support the 
implementation process. These measures included an observation estimating the percent appropriate hand hygiene 
practice by health care workers, percent of indicated cases placed in contact precautions at admission, and screening 
at admission for MRSA colonization per 1,000 admissions. These measures were collected over time before and 
after the intervention program.  
Microbiologic and infection control data from 14 hospitals around the Indianapolis metro area are collected and 
stored in the INPC (Indianapolis Network for Patient Care) system an extensive network of real-time electronic 
interfaces with hospital information systems, and are reflected in Careweb, a secure web-based application. We 
integrated local data from the Indianapolis hospitals on patients previously colonized or infected with MRSA into a 
MRSA Case Registry.  We developed an electronic data collection tool for use at individual hospitals to track 
compliance rates with the intervention implementation and to share data on MRSA cases with our MRSA registry.   
In certain hospital systems, this initiative depended upon implementation of the CDC’s WHO-NET software to 
capture the clinical incidence measure from each hospital’s data stream. Dr. John Stelling adapted the automated 
download of MRSA clinical incidence data and the CDC MRSA Prevention Initiative to use the lab database to 
build a clinical incidence measure of new MRSA at the participating hospitals. WHO-NET software, a flexible, 
user-friendly tool for the management and analysis of microbiology test results, was offered to participating 
hospitals.  
We coordinated with hospitals to develop a common data infrastructure that allow data sharing, including common 
process based and outcomes measures as required.  This infrastructure development necessitated refining current 
data collection tools and developing common strategies for application of the tools within the intervention. These 
efforts were leveraged by the existing INPC machinery, including the Master Patient Index function, to ensure 
unique linkage of records across disparate sites.  By uniquely identifying patients across institutions, we created a 
longitudinal history of a patient’s record of infection and prevented redundant entry of cases. Where possible, we 
integrated with existing hospital data sources (e.g. ADT, microbiology) to minimize administrative burden. During 
phase I, data from all Indianapolis hospitals was manually entered into a database when the data was available from 
the hospitals. As much as possible, we automated this process by working with the IT staff at each of these hospitals 
to determine which data could be provided in a predetermined format to import the data into the database and 
reduce/eliminate data transcription errors.  
Implementation Activities  
Qualitative data was collected to 1) understand the implementation activities associated with the spread of MRSA 
prevention and control practices and 2) assess lessons learned during the implementation. Qualitative data was 
collected using a two-tiered series of semi-structured interviews (the implementation plan interview with the project 
leader at each system, and later, key informant interviews with other project members and leadership to discover 
lessons learned). We collected information about implementation activities and lessons learned from a total of 33 
key informants (team leaders, implementation team members, coaches, and project leadership).  These key 
informants were identified by the project team leads at each of the participating hospital system and included a 
diverse group representing infection control providers, nurses, physicians, ward clerks, transportation personnel, 
respiratory therapy, lab directors, unit leaders, VPs of nursing, chief medical officers, dietary personnel, 
environmental services, and administration assistants. The majority of the study units were intensive care units.   
For the first round of interviews aimed at understanding the implementation activities, team leaders from each 
hospital or hospital system participated. Implementation Activities interviews were conducted between June, 2011 
and August, 2011. The implementation plan interview guide was developed based on the goals of identifying 
successes, challenges and key lessons learned in implementing MRSA reduction efforts. This interview guide 
included questions to assess characteristics of the participating hospitals, the degree of involvement of frontline staff 
and physicians in MRSA reduction efforts, descriptions of the specific MRSA reduction efforts implemented (i.e., 
activities and timelines), characteristics of the teams implementing these interventions (i.e., personnel involved), 
assessments of the projects (methods, outcomes), challenges encountered, solutions for the challenges, and lessons 
learned. The interview followed a semi-structured format with the option for the interviewer to ask follow-up 
questions as appropriate to understand the implementation activities associated with the MRSA reduction effort. 
Based on these interviews, our measures of implementation activities included assessments of the resources 
available to the team, team meeting frequency, types of educational sessions held and their target audience, and data 
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feedback mechanisms to support process adherence measurement.  Our approach to evaluating the implementation 
was also shaped by the interviews. 
For the second round of interviews, questions included: “What were the 2 or 3 most important activities or tasks that 
were implemented as part of the MRSA project?”; “What are your 3 key learnings?” 
Barriers to Fostering Change:  
Using the qualitative data from the interviews to assess lessons learned, we identified barriers to and strategies for 
implementing MRSA reduction practices. The primary barriers to fostering change were time constraints, resistance 
to change, poor communication, and resident turnover. Respondents consistently mentioned that finding time to 
participate in the MRSA project was a barrier. Logistically, attendance at meetings can be difficult for employees 
whose primary responsibility is direct patient care. Moreover, finding coverage for units so that a large number of 
employees can attend the same meeting is complicated.  Resistance to change and how to overcome that resistance 
was a focus of the interview.  Many different occupational groups were mentioned as non-compliant with the MRSA 
reduction practices. The most commonly mentioned group was physicians (which includes both resident and staff 
physicians).  Poor communication took many different forms for this project. Communication about MRSA status 
across units was one example. In other cases, communication between project personnel and leadership was poor. 
The communication with the leadership required more structured time that was face-to-face (compared with e-mail 
updates about the MRSA project).  
Strategies for Implementing MRSA Reduction Practices:  
Strategies participants consistently identified that worked to overcome barriers to change included the following: 
accountability, awareness, engagement, reinforcement, tailored intervention, teamwork, support, and resources.  
Accountability. Accountability refers to the instances in which healthcare workers were held responsible for 
complying with the MRSA reduction practices. Two types of accountability were used to enforce compliance. One 
type relied on managers or other superiors talking one-on-one with staff, residents, or other physicians who were not 
following isolation procedures or hand hygiene protocols.  For example, a key informant said that "I took names and 
I would send it on to Infection Control and they took care of it." Another type of accountability involved co-workers 
speaking to one another or to other providers who were not following isolation and hand hygiene protocols.   
Awareness. Awareness of MRSA reduction practices and of the rate, severity, and impact on patients and staff of 
MRSA infections was raised in various ways as part of the implementation activities. Some of the activities reported 
as raising awareness were hand hygiene campaigns, kickoff meetings, individual stories, and active surveillance.  
Engagement. The members of the local MRSA project team fostered engagement. Respondents indicated that 
having frontline staff as part of the project team was critical. Another project member characterized it as “it works 
better and things are adopted better if it’s their idea; then they don’t just come you know with an edict down from 
infection control.” Also, credible clinicians were important because they gained attention for the MRSA reduction 
project. The inclusion of a physician champion was noted as important for engaging other physicians in the MRSA 
reduction effort.  
Reinforcement. One reportedly effective strategy was providing feedback to frontline staff. Seeing decreases in 
MRSA rates provided tangible evidence that the new practices were effective. A resilient attitude and sense of 
empowerment by team and staff were also identified as reinforcing change and keeping the project moving forward. 
Examples of a resilient attitude include "when it was frustrating" "and I felt like throwing in the towel" another 
project member "encouraged me to stay on and told me I couldn't leave the project;" and "failure wasn't an option." 
Tailoring the intervention. Tailoring the intervention to local systems, whether it be a unit, floor, or hospital system, 
proved to be important for successful implementation. While the MRSA Bundle was identical in each participating 
system and the implementation plans similar, the flexibility and willingness to let front line staff help design and 
adapt the local implementation was viewed as highly beneficial.  
Teamwork. Many respondents mentioned teamwork and team members as a key predictor of success. The 
involvement of different levels of staff, leadership, and especially multiple departments was often cited as key. A 
team that included frontline nursing staff, environmental services, unit leaders, dietary personnel, physicians, 
transport staff, and leadership was a common model used. This approach is consistent with the increasing literature 
regarding multi-team systems. 
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Support and Resources. Support and resources included adding staff, providing financial support to the project, 
participating in an inter-hospital collaborative, having adequate IT support, and leadership support.  
Dissemination Strategies 
Our dissemination strategy included the incorporation of effective facilitated dissemination, spread, and marketing 
using a conceptual framework incorporating principles of social and network marketing, diffusion of innovations, 
positive deviance drawn from complexity science, and knowledge management.  
To foster learning and disseminate findings we used several concurrent approaches, including: 
A. An electronic environment for communication and sharing for all interested parties at our partner institution. We 
instituted an online communication and sharing system using BASECAMP with over 150 registered users from 
multiple different national hospital systems, four different research systems, and our AHRQ and CDC 
representatives. This provided a regular and open means of communication of ideas, documents, schedules, and 
results.  
B. In months 6, 12, and 18, hospital leaders, infection control practitioners, and the research team attended a one-day 
MRSA summit to discuss grant progress, issues, and next steps. We had three (two hosted by the Indianapolis 
research team and one hosted by our University Health Network partner in Toronto, Ontario, Canada) 1-1.5 day 
MRSA summits at these time points. Each meeting provided our network with the opportunity to review progress, 
identify barriers, and share stories of success. Notes from these well-attended meetings were shared with the entire 
group electronically in BASECAMP. At two of our meetings we facilitated tours of participating study units open to 
attendees. This allowed our network members to see “first hand” how implementation and change happen in the 
field.  
C. We created and disseminated case studies for this project. Our case studies illustrated how hospital systems were 
able to implement the intervention bundle, as well as how they were able to overcome common pitfalls/barriers. 
Here we provided an overall summary of the case studies of all participating hospital systems, in which specific 
hospital results will not be identified.  In addition, we have developed and shared a more detailed version for each of 
the participating systems summarizing and sharing their specific results. 
D. We sent outcomes of the research results and subsequent intervention assessments to interested stakeholders, 
relevant professional organizations, research centers, and regional and national meetings. Members of our research 
team and hospital partners gave presentations at multiple national meetings.  
E. We employed information technology and media communications solutions to foster ongoing dialogue and 
conversation about collaboration and dissemination. These included videoconferencing to conduct interviews, 
training, and gather feedback on the various interventions being deployed. We also used collaborative and project 
management software to improve communications and outcomes dissemination. This allowed for capabilities such 
as real-time document sharing, editing, presentations, scheduled meetings, invitations, etc.   
F. We also used standards-based products and technologies to deliver information and improve communications 
with the appropriate audiences. These included list managers, threaded discussion groups, web-based topical forums, 
web & podcasts, CBT delivery and archives, document sharing, delivery, and archival software. We developed a 
FIGHT MRSA Blog with posting and editing capabilities taught and given to our network members to share news 
from their respective health systems. Additionally, our Plexus partners developed a similar blog that is used to 
communicate with their network of interested partners. 
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G. We disseminated information from the project in presentations at regional and national meetings, as well as 
through publications in peer-reviewed scientific journals. We are currently developing and further refining several 
other manuscripts for submission. 
Impact of the Intervention 
Handwashing compliance and admission and discharge screening increased during phase I and remained high in 
phase II for hospitals that participated in both phases.  Analysis of MRSA rates (per 1000 bed days) by hospital 
system revealed a significant decrease in daily rate of CLABSI during post implementation compared to baseline 
period. For example, MRSA CLABSI decreased during the post-implementation period. Similarly, in phase II, 
MRSA BSI incident rate ratios decreased 85% in the implementation period, compared to baseline (p=0.012). Rates 
in the 1 year post-implementation period remained 32% lower. MRSA CLABSI reduced 84% during the post-
implementation period (p=0.046). The details on the effectiveness of the intervention will be reported separately. 
Informatics and Data Challenges 
The data collection, integration, and analysis process was complex and multifaceted. One of the realities of this 
project was that each hospital system had its unique IT departmental structure, as well as unique data systems. 
Notably, some hospitals have robust IT structure/systems with dedicated data analysts, while other hospitals are 
manually tracking data using workbooks (e.g., Microsoft Excel™) and have a single data analyst for the entire 
hospital. Regardless of the size of the IT support team, essentially every hospital had an understaffed IT group, 
given current demand for operational priorities. 
We examined the key informant interviews of team members to better understand the implementation efforts, 
looking specifically for reports of challenges with data, reporting or informatics (Table 1).  Communication 
challenges were relatively common, in terms of scope and type of data required as well as data preparation 
requirements prior to data transfer.   
Table 1. Identified data and informatics barriers or challenges and suggested solutions. 
Data Challenges Solutions 
Communication challenges Developing regular written updates of progress, action items, 
timelines and project management tools 
Lack of sufficient IT support (insufficient 
IT staff, competing demands [e.g., switch 
in EHR vendors, or other hospital 
priorities] 
Project team may need to discuss alternate strategies, such as 
negotiating more limited IT support from the hospital, 
suggesting alternate data capture strategies, or the 
collaborative providing data management support on-site  
Limited data availability Project team working with IT departments and team leaders, 
automating data entry, leveraging existing informatics 
structure, availability of data from other sources 
Commercial entities (e.g., microbiologic 
labs, commercial surveillance tools, 
commercial dialysis units, etc,)  may not 
consider data sharing a priority 
Discussion with both hospital and commercial entities about 
expected return on investment 
Incomplete/slow communication of 
MRSA infection status 
Automated alerts of prior infection status, use of PCR tests 
for quicker results 
Data silos (e.g., microbiology, infection 
surveillance, ADT) may not be integrated 
Develop plans for integration of data with representatives of 
all units, focusing on value of a shared data architecture 
Inability to see regular progress reports Develop unit-level reporting at regular (weekly or monthly) 
intervals to support engagement of staff and sustain efforts. 
 
We found multiple barriers to data sharing and management including: 1) hospitals with significantly reduced and 
backlogged IT staff; 2) “mid-stream” switch in IT vendor systems at two hospitals requiring full effort of key 
resources; 3) unanticipated competition for IT staff with both industry and stimulus‐funded projects at participating 
hospitals; 4) loss of lead data analysts/ personnel who were directly supporting our project.  We also found 
challenges in applying the WHOnet approach to data sharing, with multiple competing demands in the area of public 
health informatics within the health systems (or state initiatives), the Regenstrief Institute, and supporting CDC 
initiatives. Furthermore, externally‐owned entities, such as laboratories that manage microbiology data may not 
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necessarily be on board with the need for data sharing with a “research organization”. We also found differing 
experiences among and interpretations by key staff at several facilities with regard to Institutional Review Board 
(IRB) issues, data sharing, and HIPAA rules significantly impacted the ability of key staff at a participating hospital 
to share data. 
Solutions 
To address these challenges, we partnered with critical staff from information systems, infection prevention, 
administration and microbiology within each health system, in order to continue to work together to resolve 
problems.  We also developed detailed documentation of the data architecture and data management plans, and 
dynamically re‐adjusted approaches as needed to accommodate the multiple information systems and sources, as 
well as the shifting organizational priorities within hospitals. This process included developing a detailed data 
requirement document that had been thoroughly vetted by our data team and investigators for each of the hospitals. 
This document included the set of study measures, required data elements, date ranges, likely source systems, 
alternative approaches, standards/definitions and reporting methodology. We reviewed the standards with each 
hospital data team to ensure that future information was provided in a compatible format.  
Hospital staff and leadership voiced a strong interest in being able to see data on the impact of interventions, provide 
rapid feedback on progress and support further implementation and spread of techniques to reduce MRSA.  The 
measurement of these data was identified as a significant need to support the spread of adoption of evidence-based 
practices to reduce MRSA infection. As a result, we developed the ability to generate ad hoc reports to meet the 
needs of the MRSA teams. These tools were designed in concert with the users, reviewed and piloted by them, and 
then made available to participating hospitals for internal quality control and research purposes.  
Data availability and ability to readily generate reports were both highly valued by participants, but very challenging 
to obtain in most hospital infection prevention programs.  
To facilitate data collection, we reviewed the standards with each hospital data team to ensure that future 
data/information was provided in a compatible format. To meet the needs of each hospital system, we advanced in 
parallel tracks with each of the sites. For the Indianapolis hospitals, we were able to collect some required data 
elements from the Indiana Network for Patient Care (INPC) to validate the data provided from the hospitals where 
available. Notably, some INPC MRSA data is insufficiently structured and had to be supplemented with 
well‐structured and coded data from the hospitals, their vendors, or WHOnet. 
Because of the challenges in obtaining adequately structured microbiologic and infection prevention data in 
hospitals, CDC has been supporting the efforts of Harvard’s WHO Collaborating Centre for Surveillance of 
Antimicrobial Resistance, and its WHONet. Commercial packages, such as MedMined ™ are available at a few 
larger, well-funded hospitals, but the costs are prohibitive for many hospitals. Further research and development is 
needed to create user-friendly tools, which can capture and make available for analysis such data to hospitals and 
other staff.   
We witnessed many competing demands on the infection preventionists, quality improvement personnel and IT 
specialists. In light of the many competing demands for data management and IT support at certain hospitals, we 
feel it is important for funding agencies to consider the need for providing support to participating hospitals for the 
data management needs for participation.   
It should also be noted that many of our intervention hospitals had already implemented the MRSA Bundle in our 
Phase 1 project, thus their rates of MRSA were already very low. To achieve a significant reduction from this 
baseline is even more remarkable. 
Conclusions 
The significance of this project lies in its innovative strategies to foster organizational change, data sharing, system 
redesign and sustainability.  The size of the reduction in MRSA infections over time is considerable and sustained. 
Multiple organizations that have embraced these strategies have found them transformative in how they address 
quality and performance issues in general. A Chief Nursing Officer noted that this project has permanently 
transformed their organization for the better, through demonstrating how to implement and sustain change.  
The data and informatics challenges in fostering multihospital intervention studies are considerable. Effective data 
sharing and registry development require partnering with multiple hospital data systems stewards, developing 
detailed documentation of the data architecture and data management plans, and dynamically re‐adjusting 
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approaches as needed to accommodate multiple information systems and the shifting organizational priorities within 
hospitals. Regular review of data standards with each data team is important to ensure that future information is 
provided in a compatible format.  
In any intervention study, it is critical to provide rapid feedback on progress in order to support further 
implementation and sustainability.  The ability to generate ad hoc reports to meet the needs of the implementation 
teams is important for ongoing engagement of the hospital staff and for evaluation purposes. Further research and 
development are needed to create user-friendly tools, which can capture and make available such data for analysis.   
We are currently applying these strategies to other hospital-acquired infections, and are using tools such as natural 
language processing, to develop better electronic surveillance systems. All hospitals with multidrug resistant 
infections such as MRSA should actively investigate strategies for effective prevention. In our experience, these are 
likely to include surveillance, staff training and engagement, and system redesign approaches.  Further investments 
in research and development are needed to foster development of software and data standards to create user-friendly 
tools which can capture and make available for analysis infection prevention and quality improvement data to 
hospitals and other staff, in order to support organizational change efforts.  
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